Last $142.42 USD
Change Today 0.00 / 0.00%
Volume 0.0
AKBLF On Other Exchanges
Symbol
Exchange
Copenhagen
OTC US
Berlin
OTC US
As of 8:10 PM 08/11/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for alk-abello a/s (AKBLF)

Year over year, ALK-Abelló A/S has seen revenues fall from kr2.3B DKK to kr2.2B DKK. This along with an increase in the cost of goods sold expense has led to a reduction in the bottom line from kr209.0M DKK to kr61.0M DKK.
View Income Statement In U.S. Dollar
Currency in
Millions of Danish Krones
As of:Dec 31
2010
Reclassified
DKK
Dec 31
2011
DKK
Dec 31
2012
Restated
DKK
Dec 31
2013
DKK
4 Year
Trend
Revenues2,159.02,348.02,345.02,244.0
TOTAL REVENUES2,159.02,348.02,345.02,244.0
Cost of Goods Sold654.0611.0648.0697.0
GROSS PROFIT1,505.01,737.01,697.01,547.0
Selling General & Admin Expenses, Total951.0985.01,004.0955.0
R&D Expenses366.0455.0511.0463.0
Other Operating Expenses-4.0-2.0---1.0
OTHER OPERATING EXPENSES, TOTAL1,313.01,438.01,515.01,417.0
OPERATING INCOME192.0299.0182.0130.0
Interest Expense-6.0-8.0-11.0-11.0
Interest and Investment Income3.021.09.0--
NET INTEREST EXPENSE-3.013.0-2.0-11.0
Currency Exchange Gains (Loss)18.09.0-3.0-12.0
Other Non-Operating Income (Expenses)-------1.0
EBT, EXCLUDING UNUSUAL ITEMS207.0321.0177.0106.0
Merger & Restructuring Charges-----64.0-22.0
Gain (Loss) on Sale of Investments------20.0
EBT, INCLUDING UNUSUAL ITEMS207.0321.0113.0104.0
Income Tax Expense79.0121.059.043.0
Earnings from Continuing Operations128.0200.054.061.0
EARNINGS FROM DISCOUNTINUED OPERATIONS----155.0--
NET INCOME128.0200.0209.061.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS128.0200.0209.061.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS128.0200.054.061.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AKBLF:US $142.42 USD 0.00

AKBLF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allergy Therapeutics PLC 24.50 GBp +1.00
DBV Technologies SA €21.10 EUR 0.00
Merck & Co Inc $60.46 USD +0.255
Sanofi €83.39 EUR +0.45
Stallergenes SA €53.55 EUR 0.00
View Industry Companies
 

Industry Analysis

AKBLF

Industry Average

Valuation AKBLF Industry Range
Price/Earnings 38.7x
Price/Sales 3.0x
Price/Book 3.1x
Price/Cash Flow 36.2x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALK-ABELLO A/S, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.